United States · FDA National Drug Code directory
TECARTUS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71287-219_17c4a716-a22e-486d-b633-4be6c2453266
- Product NDC
- 71287-219
- Form
- SUSPENSION
- Composition / generic term
- brexucabtagene autoleucel
- Labeler
- Kite Pharma, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20200724
- Source listing expiry
- 20271231
Source-listed ingredients
- BREXUCABTAGENE AUTOLEUCEL — 2000000 1/68mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BAG in 1 PACKAGE (71287-219-02) / 68 mL in 1 BAG (71287-219-01) · 71287-219-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →